Literature DB >> 25523288

Impaired fasting pyloric compliance in gastroparesis and the therapeutic response to pyloric dilatation.

G Gourcerol1, F Tissier, C Melchior, J Y Touchais, E Huet, G Prevost, A M Leroi, P Ducrotte.   

Abstract

BACKGROUND: Pyloric pressure and compliance have never been investigated in health nor gastroparesis. AIM: We hypothesised that pyloric pressure and/or compliance may be altered in gastroparesis.
METHODS: Fasting pyloric pressure and compliance were investigated in 21 healthy volunteers (HV), 27 gastroparetic patients (GP) and 5 patients who had undergone oesophagectomy without pyloroplasty as positive controls. Under videofluoroscopic control, pyloric compliance and pressure were measured by the EndoFLIP technique. Gastric emptying half time (T1/2 ) using (13) C-octanoic acid breath test, as well as symptoms and quality of life (GIQLI score) were also monitored.
RESULTS: Mean fasting pyloric compliance was measured at 25.2 ± 2.4 mm²/mmHg in HV, and was lower both in GP (16.9 ± 2.1 mm²/mmHg; P < 0.05) and patients with oesophagectomy (10.9 ± 2.9 mm²/mmHg; P < 0.05). By contrast, fasting pyloric pressure was not different among groups. Fasting pyloric compliance and pressure correlated with T1/2 in GP (R = -0.43; P = 0.04). Fasting pyloric compliance, but not pressure, correlated with symptoms and GIQLI score. Pyloric dilation in 10 GP with low fasting pyloric compliance (<10 mm²/mmHg) increased compliance from 7.4 ± 0.4 to 20.1 ± 4.9 mm²/mmHg (P < 0.01) and improved the GIQLI score from 72.5 ± 5.5 to 89.3 ± 6.1 (P = 0.04).
CONCLUSION: This prospective study assessed pyloric compliance for the first time, and showed that fasting pyloric compliance is decreased in gastroparetic patients and is associated with T1/2 , symptoms and quality of life. This suggests that pyloric compliance may be a new relevant metric in gastroparetic patients, and may be useful to target patients for pyloric dilation or botulinum toxin injection.
© 2014 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25523288     DOI: 10.1111/apt.13053

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  28 in total

Review 1.  Botulinum Toxin Injection for Treatment of Gastroparesis.

Authors:  Trisha S Pasricha; Pankaj J Pasricha
Journal:  Gastrointest Endosc Clin N Am       Date:  2018-09-28

2.  Per-Oral Pyloromyotomy (POP) for Medically Refractory Post-Surgical Gastroparesis.

Authors:  Andrew T Strong; Joshua P Landreneau; Michael Cline; Matthew D Kroh; John H Rodriguez; Jeffrey L Ponsky; Kevin El-Hayek
Journal:  J Gastrointest Surg       Date:  2019-02-26       Impact factor: 3.452

3.  Endoscopic Approaches to Gastroparesis.

Authors:  Kevin Liu; Thomas Enke; Aziz Aadam
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-09

Review 4.  Pyloric Therapies for Gastroparesis.

Authors:  Nitin K Ahuja; John O Clarke
Journal:  Curr Treat Options Gastroenterol       Date:  2017-03

5.  G-POEM for Gastroparesis: Is There Pressure to Go with the Flow?

Authors:  Allen A Lee; William L Hasler
Journal:  Dig Dis Sci       Date:  2018-09       Impact factor: 3.199

6.  Gastric Per Oral Endoscopic Myotomy (G-POEM) for the Treatment of Refractory Gastroparesis: Early Experience.

Authors:  Zubair Malik; Rahul Kataria; Rani Modayil; Adam C Ehrlich; Ron Schey; Henry P Parkman; Stavros N Stavropoulos
Journal:  Dig Dis Sci       Date:  2018-02-22       Impact factor: 3.199

Review 7.  Diabetes and the Stomach.

Authors:  Allen A Lee; William L Hasler
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

Review 8.  Gastric Peroral Endoscopic Pyloromyotomy Therapy for Refractory Gastroparesis.

Authors:  Petros C Benias; Mouen A Khashab
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

Review 9.  Endoscopic Therapies for Gastroparesis.

Authors:  Andrew Su; Jeffrey L Conklin; Alireza Sedarat
Journal:  Curr Gastroenterol Rep       Date:  2018-04-23

Review 10.  Gastroparesis in the 2020s: New Treatments, New Paradigms.

Authors:  Amol Sharma; Michael Coles; Henry P Parkman
Journal:  Curr Gastroenterol Rep       Date:  2020-03-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.